Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick L Ruberg

Showing results (61-70 of 109) with videos related to

Pageof 11
Sort By:
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|May 16, 2026
Cardiac amyloidosis: Disease overview and novel pathophysiologic insightsGregorio Tersalvi, Daniela Tomasoni, Roxanne Coderre, et al.
Circulation. Heart Failure|September 5, 2019
Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac AmyloidosisMathew S Maurer, Sabahat Bokhari, Thibaud Damy, et al.
Advances in Therapy|June 4, 2024
Advancing Transthyretin Amyloidosis Drug Development in an Evolving Treatment Landscape: Amyloidosis Forum Meeting ProceedingsMathew S Maurer, Prem Soman, Adrian Hernandez, et al.
Circulation. Cardiovascular Imaging|November 15, 2022
Optimal Echocardiographic Parameters to Improve the Diagnostic Yield of Tc-99m-Bone Avid Tracer Cardiac Scintigraphy for Transthyretin Cardiac AmyloidosisSarah Am Cuddy, Yesh Datar, Gavin Ovsak, et al.
Plos One|March 30, 2023
Clinical and social determinants of health features of SARS-CoV-2 infection among Black and Caribbean Hispanic patients with heart failure: The SCAN-MP StudyJonathan B Edmiston, Elizabeth G Cohn, Sergio L Teruya, et al.
JACC. Cardiovascular Imaging|March 19, 2018
Native T1 and Extracellular Volume in Transthyretin AmyloidosisAna Martinez-Naharro, Tushar Kotecha, Karl Norrington, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 8, 2019
Early Detection of Multiorgan Light-Chain Amyloidosis by Whole-Body <sup>18</sup>F-Florbetapir PET/CTEric C Ehman, M Samir El-Sady, Marie F Kijewski, et al.
JACC. Heart Failure|September 7, 2024
Functional Status and Quality of Life in Light-Chain Amyloidosis: Advanced Imaging, Longitudinal Changes, and OutcomesOlivier F Clerc, Shilpa Vijayakumar, Sarah A M Cuddy, et al.
JACC. Cardiooncology|November 29, 2022
Outcomes by Cardiac Stage in Patients With Newly Diagnosed AL Amyloidosis: Phase 3 ANDROMEDA TrialMonique C Minnema, Angela Dispenzieri, Giampaolo Merlini, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|March 26, 2025
Abnormal global longitudinal strain and reduced serum inflammatory markers in cardiac AL amyloidosis patients without significant amyloid fibril depositionCamille V Edwards, Grace M Ferri, Josue Villegas-Galaviz, et al.
Pageof 11

Showing results (61-70 of 109) with videos related to

Sort By:
Pageof 11
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|May 16, 2026
Cardiac amyloidosis: Disease overview and novel pathophysiologic insightsGregorio Tersalvi, Daniela Tomasoni, Roxanne Coderre, et al.
Circulation. Heart Failure|September 5, 2019
Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac AmyloidosisMathew S Maurer, Sabahat Bokhari, Thibaud Damy, et al.
Advances in Therapy|June 4, 2024
Advancing Transthyretin Amyloidosis Drug Development in an Evolving Treatment Landscape: Amyloidosis Forum Meeting ProceedingsMathew S Maurer, Prem Soman, Adrian Hernandez, et al.
Circulation. Cardiovascular Imaging|November 15, 2022
Optimal Echocardiographic Parameters to Improve the Diagnostic Yield of Tc-99m-Bone Avid Tracer Cardiac Scintigraphy for Transthyretin Cardiac AmyloidosisSarah Am Cuddy, Yesh Datar, Gavin Ovsak, et al.
Plos One|March 30, 2023
Clinical and social determinants of health features of SARS-CoV-2 infection among Black and Caribbean Hispanic patients with heart failure: The SCAN-MP StudyJonathan B Edmiston, Elizabeth G Cohn, Sergio L Teruya, et al.
JACC. Cardiovascular Imaging|March 19, 2018
Native T1 and Extracellular Volume in Transthyretin AmyloidosisAna Martinez-Naharro, Tushar Kotecha, Karl Norrington, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 8, 2019
Early Detection of Multiorgan Light-Chain Amyloidosis by Whole-Body <sup>18</sup>F-Florbetapir PET/CTEric C Ehman, M Samir El-Sady, Marie F Kijewski, et al.
JACC. Heart Failure|September 7, 2024
Functional Status and Quality of Life in Light-Chain Amyloidosis: Advanced Imaging, Longitudinal Changes, and OutcomesOlivier F Clerc, Shilpa Vijayakumar, Sarah A M Cuddy, et al.
JACC. Cardiooncology|November 29, 2022
Outcomes by Cardiac Stage in Patients With Newly Diagnosed AL Amyloidosis: Phase 3 ANDROMEDA TrialMonique C Minnema, Angela Dispenzieri, Giampaolo Merlini, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|March 26, 2025
Abnormal global longitudinal strain and reduced serum inflammatory markers in cardiac AL amyloidosis patients without significant amyloid fibril depositionCamille V Edwards, Grace M Ferri, Josue Villegas-Galaviz, et al.
Pageof 11